Φορτώνει......
Targeting α-synuclein for treating Parkinson’s disease: mechanistic and therapeutic considerations
Progressive neuronal cell loss in a small subset of brainstem and mesencephalic nuclei and widespread aggregation of the α-synuclein protein in the form of Lewy bodies and Lewy neurites are neuropathological hallmarks of Parkinson’s disease. Most cases occur sporadically, but mutations in several ge...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Lancet Neurol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217462/ https://ncbi.nlm.nih.gov/pubmed/26050140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(15)00006-X |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|